Phase II Trial Opens: Digital Treatment Tool Plus GLP-1 Agonists vs Standard Care in Adolescent Obesity — What Clinicians Need to Know

References

1. 1.Cole, T. J., & Lobstein, T. (2012). Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity. Pediatric Obesity, 7(4), 284-294. https://doi.org/10.1111/j.2047-6310.2012.00064.x
2. 2.Flores Mateo, G., Granado-Font, E., Ferré-Grau, C., & Montaña-Carreras, X. (2015). Mobile Phone Apps to Promote Weight Loss and Increase Physical Activity: A Systematic Review and Meta-Analysis. Journal of Medical Internet Research, 17(11), e4836. https://doi.org/10.2196/jmir.4836
3. 3.Ford, I., & Norrie, J. (2016). Pragmatic Trials. New England Journal of Medicine, 375(5), 454-463. https://doi.org/10.1056/NEJMra1510059
4. 4.Hampl, S. E., Hassink, S. G., Skinner, A. C., Armstrong, S. C., Barlow, S. E., Bolling, C. F., ... & Woolford, S. J. (2023). Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity. Pediatrics, 151(2), e2022060640. https://doi.org/10.1542/peds.2022-060640
5. 5.Jebeile, H., Kelly, A. S., O'Malley, G., & Baur, L. A. (2022). Obesity in children and adolescents: epidemiology, causes, assessment, and management. The Lancet Diabetes & Endocrinology, 10(5), 351-365. https://doi.org/10.1016/S2213-8587(22)00047-X
6. 6.Karolinska Institutet. (2024). Evaluation of a Digital Treatment Tool in Combination With Obesity Medications. ClinicalTrials.gov. NCT06836284. https://clinicaltrials.gov/study/NCT06836284
7. 7.Kelly, A. S., Auerbach, P., Barrientos-Perez, M., Gies, I., Hale, P. M., Marcus, C., ... & Arslanian, S. A. (2020). A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity. New England Journal of Medicine, 382(22), 2117-2128. https://doi.org/10.1056/NEJMoa1916038
8. 8.Kumar, S., & Kelly, A. S. (2017). Review of Childhood Obesity: From Epidemiology, Etiology, and Comorbidities to Clinical Assessment and Treatment. Mayo Clinic Proceedings, 92(2), 251-265. https://doi.org/10.1016/j.mayocp.2016.09.017
9. 9.Mead, E., Brown, T., Rees, K., Azevedo, L. B., Whittaker, V., Jones, D., ... & Ells, L. J. (2017). Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years. Cochrane Database of Systematic Reviews, 6, CD012651. https://doi.org/10.1002/14651858.CD012651
10. 10.Ryder, J. R., Kaizer, A., Rudser, K. D., Gross, A., Kelly, A. S., & Fox, C. K. (2023). Digital health interventions for pediatric obesity: A systematic review. Obesity Reviews, 24(3), e13521. https://doi.org/10.1111/obr.13521
11. 11.Skelton, J. A., Irby, M. B., Beech, B. M., & Rhodes, S. D. (2020). Family-based treatment for childhood obesity: for whom and when? Current Opinion in Pediatrics, 32(4), 520-526. https://doi.org/10.1097/MOP.0000000000000888
12. 12.Weghuber, D., Barrett, T., Barrientos-Pérez, M., Gies, I., Hesse, D., Jeppesen, O. K., ... & Kelly, A. S. (2022). Once-Weekly Semaglutide in Adolescents with Obesity. New England Journal of Medicine, 387(24), 2245-2257. https://doi.org/10.1056/NEJMoa2208601